Key takeaways
Eliquis (apixaban) and Pradaxa (dabigatran) are both blood thinners used to prevent and treat blood clots, but they work in different ways. Eliquis is typically taken twice daily and has an FDA-approved generic version that may not be available until 2026. Pradaxa is also taken twice daily but doesn’t have a generic version available. Eliquis is considered a first-choice treatment for preventing stroke in people with nonvalvular atrial fibrillation and might be safer for those with kidney problems. Pradaxa, on the other hand, requires careful use in people with kidney problems and has a higher risk of stomach bleeding, especially in those over 75. Both medications can cause bleeding, but Pradaxa has an available antidote in case of emergency.
